标题
Roles of Mitogen-Activated Protein Kinases in Osteoclast Biology
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 10, Pages 3004
出版商
MDPI AG
发表日期
2018-10-02
DOI
10.3390/ijms19103004
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- IL-17A regulates the autophagic activity of osteoclast precursors through RANKL-JNK1 signaling during osteoclastogenesis in vitro
- (2018) Dianshan Ke et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The MEK5/ERK5 mitogen-activated protein kinase cascade is an effector pathway of bone-sustaining bisphosphonates that regulates osteogenic differentiation and mineralization
- (2018) Christian Adam et al. BONE
- A ERK/RSK-mediated negative feedback loop regulates M-CSF–evoked PI3K/AKT activation in macrophages
- (2018) Lijun Wang et al. FASEB JOURNAL
- LRP1 Suppresses Bone Resorption in Mice by Inhibiting the RANKL-Stimulated NF-κB and p38 Pathways During Osteoclastogenesis
- (2018) Di Lu et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Cepharanthine Prevents Estrogen Deficiency-Induced Bone Loss by Inhibiting Bone Resorption
- (2018) Chen-he Zhou et al. Frontiers in Pharmacology
- TNF-α promotes osteoclastogenesis through JNK signaling-dependent induction of Semaphorin3D expression in estrogen-deficiency induced osteoporosis
- (2017) Chenglin Sang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Pmepa1 induced by RANKL-p38 MAPK pathway has a novel role in osteoclastogenesis
- (2017) Noboru Funakubo et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Combination of IL-6 and sIL-6R differentially regulate varying levels of RANKL-induced osteoclastogenesis through NF-κB, ERK and JNK signaling pathways
- (2017) Wei Feng et al. Scientific Reports
- p38α MAPK regulates proliferation and differentiation of osteoclast progenitors and bone remodeling in an aging-dependent manner
- (2017) Qian Cong et al. Scientific Reports
- Analysis of Nkx3.1:Cre-driven Erk5 deletion reveals a profound spinal deformity which is linked to increased osteoclast activity
- (2017) Carolyn J. Loveridge et al. Scientific Reports
- Clinical Pharmacokinetics and Pharmacodynamics of Afatinib
- (2016) Sven Wind et al. CLINICAL PHARMACOKINETICS
- LIS1 Regulates Osteoclastogenesis through Modulation of M-SCF and RANKL Signaling Pathways and CDC42
- (2016) Shiqiao Ye et al. International Journal of Biological Sciences
- Selective Regulation of MAPK Signaling Mediates RANKL-dependent Osteoclast Differentiation
- (2016) Kyunghee Lee et al. International Journal of Biological Sciences
- IL-15 and RANKL Play a Synergistically Important Role in Osteoclastogenesis
- (2016) Iichiro Okabe et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Disturbed MEK/ERK signaling increases osteoclast activity via the Hedgehog-Gli pathway in postmenopausal osteoporosis
- (2016) Xiaojie Li et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- STAT5 is a key transcription factor for IL-3-mediated inhibition of RANKL-induced osteoclastogenesis
- (2016) Jongwon Lee et al. Scientific Reports
- Peroxiredoxin II Negatively Regulates Lipopolysaccharide-Induced Osteoclast Formation and Bone Loss via JNK and STAT3
- (2015) Hyojung Park et al. ANTIOXIDANTS & REDOX SIGNALING
- Piperine alleviates osteoclast formation through the p38/c-Fos/NFATc1 signaling axis
- (2015) Vishwa Deepak et al. BIOFACTORS
- CCN2 enhances RANKL-induced osteoclast differentiation via direct binding to RANK and OPG
- (2015) Eriko Aoyama et al. BONE
- Osteoprotegerin induces podosome disassembly in osteoclasts through calcium, ERK, and p38 MAPK signaling pathways
- (2015) Hongyan Zhao et al. CYTOKINE
- The 1,2,3-triazole derivative KP-A021 suppresses osteoclast differentiation and function by inhibiting RANKL-mediated MEK-ERK signaling pathway
- (2015) Hye Jung Ihn et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Sexual Dimorphism in MAPK-Activated Protein Kinase-2 (MK2) Regulation of RANKL-Induced Osteoclastogenesis in Osteoclast Progenitor Subpopulations
- (2015) Bethany A. Herbert et al. PLoS One
- ERK5 Activation Is Essential for Osteoclast Differentiation
- (2015) Shigeru Amano et al. PLoS One
- Curcumol suppresses RANKL-induced osteoclast formation by attenuating the JNK signaling pathway
- (2014) Mingxiang Yu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Hypericin suppresses osteoclast formation and wear particle-induced osteolysis via modulating ERK signalling pathway
- (2014) Zhengxiao Ouyang et al. BIOCHEMICAL PHARMACOLOGY
- Amyloid beta peptide is elevated in osteoporotic bone tissues and enhances osteoclast function
- (2014) Shangfu Li et al. BONE
- Interleukin-1β promotes the LC3-mediated secretory function of osteoclast precursors by stimulating the Ca2+-dependent activation of ERK
- (2014) Yeon-Ho Chung et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Blockade of CD26 Signaling Inhibits Human Osteoclast Development
- (2014) Hiroko Nishida et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Beclin-1 Is Required for RANKL-Induced Osteoclast Differentiation
- (2014) Yeon-Ho Chung et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions
- (2014) Moshe Rogosnitzky et al. Pharmacological Reports
- Correction: Differential Roles of MAPK Kinases MKK3 and MKK6 in Osteoclastogenesis and Bone Loss
- (2014) David L. Boyle et al. PLoS One
- CSF-1 Receptor Signaling in Myeloid Cells
- (2014) E. R. Stanley et al. Cold Spring Harbor Perspectives in Biology
- Ablation of Tak1 in osteoclast progenitor leads to defects in skeletal growth and bone remodeling in mice
- (2014) Bing Qi et al. Scientific Reports
- Prostaglandin D2 induces apoptosis of human osteoclasts through ERK1/2 and Akt signaling pathways
- (2013) Li Yue et al. BONE
- Bone morphogenetic protein-9 activates Smad and ERK pathways and supports human osteoclast function and survival in vitro
- (2013) David Fong et al. CELLULAR SIGNALLING
- Bone resorption is regulated by cell-autonomous negative feedback loop of Stat5–Dusp axis in the osteoclast
- (2013) Jun Hirose et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Sinomenine Suppresses Osteoclast Formation and Mycobacterium tuberculosis H37Ra-Induced Bone Loss by Modulating RANKL Signaling Pathways
- (2013) Xiaojuan Li et al. PLoS One
- Recent Researches in Triazole Compounds as Medicinal Drugs
- (2012) C. -H. Zhou et al. CURRENT MEDICINAL CHEMISTRY
- Fisetin Inhibits Osteoclast Differentiation via Downregulation of p38 and c-Fos-NFATc1 Signaling Pathways
- (2012) Sik-Won Choi et al. Evidence-based Complementary and Alternative Medicine
- Dual-specificity MAP kinase phosphatases (MKPs)
- (2012) Christopher J. Caunt et al. FEBS Journal
- Ormeloxifene inhibits osteoclast differentiation in parallel to downregulating RANKL-induced ROS generation and suppressing the activation of ERK and JNK in murine RAW264.7 cells
- (2012) Geetika Kharkwal et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- TAK1 Is Essential for Osteoclast Differentiation and Is an Important Modulator of Cell Death by Apoptosis and Necroptosis
- (2012) Betty Lamothe et al. MOLECULAR AND CELLULAR BIOLOGY
- Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis
- (2012) Kazuhiro Maeda et al. NATURE MEDICINE
- Erk1 Positively Regulates Osteoclast Differentiation and Bone Resorptive Activity
- (2011) Yongzheng He et al. PLoS One
- Irreversible inhibition of RANK expression as a possible mechanism for IL-3 inhibition of RANKL-induced osteoclastogenesis
- (2010) Shruti M. Khapli et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- cAMP Modulates Macrophage Development by Suppressing M-CSF-Induced MAPKs Activation
- (2010) Ning Zhu et al. Cellular & Molecular Immunology
- Macrophage inflammatory protein-1α induces osteoclast formation by activation of the MEK/ERK/c-Fos pathway and inhibition of the p38MAPK/IRF-3/IFN-β pathway
- (2010) Masanobu Tsubaki et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis
- (2010) Marc Baud'Huin et al. JOURNAL OF PATHOLOGY
- ADAM10 Releases a Soluble Form of the GPNMB/Osteoactivin Extracellular Domain with Angiogenic Properties
- (2010) April A. N. Rose et al. PLoS One
- Role of MKP-1 in Osteoclasts and Bone Homeostasis
- (2009) Jodi Carlson et al. AMERICAN JOURNAL OF PATHOLOGY
- The Potential of p38 MAPK Inhibitors to Modulate Periodontal Infections
- (2009) Keith Kirkwood et al. CURRENT DRUG METABOLISM
- Transforming Growth Factor-β1 (TGF-β1) Induces Human Osteoclast Apoptosis by Up-regulating Bim
- (2009) Nicolas Houde et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MAP Kinase Phosphatase-1 Protects against Inflammatory Bone Loss
- (2009) R. Sartori et al. JOURNAL OF DENTAL RESEARCH
- The Mechanism of Osteoclast Differentiation Induced by IL-1
- (2009) J. H. Kim et al. JOURNAL OF IMMUNOLOGY
- Inhibition of RANK Expression and Osteoclastogenesis by TLRs and IFN- in Human Osteoclast Precursors
- (2009) J.-D. Ji et al. JOURNAL OF IMMUNOLOGY
- The -Isoform of p38 MAPK Specifically Regulates Arthritic Bone Loss
- (2009) C. Bohm et al. JOURNAL OF IMMUNOLOGY
- GM-CSF Regulates Fusion of Mononuclear Osteoclasts into Bone-Resorbing Osteoclasts by Activating the Ras/ERK Pathway
- (2009) M. S. Lee et al. JOURNAL OF IMMUNOLOGY
- Novel Pro-survival Functions of the Kruppel-like Transcription Factor Egr2 in Promotion of Macrophage Colony-stimulating Factor-mediated Osteoclast Survival Downstream of the MEK/ERK Pathway
- (2008) Elizabeth W. Bradley et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Defective Osteoclastogenesis by IKKβ-null Precursors Is a Result of Receptor Activator of NF-κB Ligand (RANKL)-induced JNK-dependent Apoptosis and Impaired Differentiation
- (2008) Jesse E. Otero et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interleukin-6 Directly Inhibits Osteoclast Differentiation by Suppressing Receptor Activator of NF-κB Signaling Pathways
- (2008) Fumio Yoshitake et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- JNK/c-Jun Signaling Mediates an Anti-Apoptotic Effect of RANKL in Osteoclasts
- (2008) Fumiyo Ikeda et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The JNK-dependent CaMK pathway restrains the reversion of committed cells during osteoclast differentiation
- (2008) E.-J. Chang et al. JOURNAL OF CELL SCIENCE
- RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice
- (2008) Sergio Vaira et al. JOURNAL OF CLINICAL INVESTIGATION
- The cell biology of bone metabolism
- (2008) H K Datta et al. JOURNAL OF CLINICAL PATHOLOGY
- Ceramide 1-phosphate stimulates macrophage proliferation through activation of the PI3-kinase/PKB, JNK and ERK1/2 pathways
- (2007) Patricia Gangoiti et al. CELLULAR SIGNALLING
- High extracellular inorganic phosphate concentration inhibits RANK-RANKL signaling in osteoclast-like cells
- (2007) Anaïs Mozar et al. JOURNAL OF CELLULAR PHYSIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now